# Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy

> **NCT04096014** · NA · RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 40 (estimated)

## Conditions studied

- Hepatic Encephalopathy

## Interventions

- **DIETARY_SUPPLEMENT:** Ensure Enlive
- **OTHER:** Standard Of Care

## Key facts

- **NCT ID:** NCT04096014
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-16
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-10-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04096014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04096014, "Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04096014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*